SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 132 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69 | -47.3% | 28,958 | +5.8% | 0.00% | -100.0% |
| Q2 2023 | $131 | -24.7% | 27,360 | -10.9% | 0.00% | 0.0% |
| Q1 2023 | $174 | +1.8% | 30,705 | +0.7% | 0.00% | 0.0% |
| Q4 2022 | $171 | -99.9% | 30,478 | -6.0% | 0.00% | -50.0% |
| Q3 2022 | $208,000 | +447.4% | 32,440 | +194.9% | 0.00% | – |
| Q2 2022 | $38,000 | -62.7% | 11,002 | -23.2% | 0.00% | -100.0% |
| Q1 2022 | $102,000 | -9.7% | 14,333 | +5.7% | 0.00% | 0.0% |
| Q4 2021 | $113,000 | +46.8% | 13,562 | +23.0% | 0.00% | – |
| Q3 2021 | $77,000 | +40.0% | 11,026 | +480.9% | 0.00% | – |
| Q2 2016 | $55,000 | +77.4% | 1,898 | +60.2% | 0.00% | – |
| Q1 2016 | $31,000 | 0.0% | 1,185 | +32.6% | 0.00% | – |
| Q4 2015 | $31,000 | – | 894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |